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For a pregnant woman, easily and safely finding out for certain whether her baby will have Down’s syndrome
is an attractive prospect. The point of non-invasive prenatal diagnosis (NIPD), as with current tests, is to give
information about the health of the foetus. It’s just that this test is risk free and doesn’t need a needle to be
inserted into a woman’s uterus. Should we worry about medicine making this test safer?
This test is an amazing development. Imagine the heartbreak of having an invasive test to then miscarry as a
result. But before we roll this test out across the NHS, we need to address important ethical questions.
Women have lots of blood tests in pregnancy and don’t always have much time to think about them. They’re
also given a small mountain of information to read. We need to make sure the women who choose this test
genuinely want it.
The potential significance of the result must be emphasised. Women also need to know testing is a choice,
not an expectation. They need time to think about whether or not they want to know if their baby will have
Down’s syndrome, and what they might do if it is found.
The timing of this test is also important. NIPD could be done early, when a pregnancy may not be “showing".
But the risk of miscarriage is also highest in the first trimester. Might it be better to wait until it is known that
the pregnancy is on-going? NIPD could, for example, replace current imperfect screening tests for Down’s
syndrome offered early in the second trimester.
NIPD forces us to think about why we offer prenatal tests. Helping women to make informed choices is the
obvious goal, but some worry that NIPD could also increase abortion rates. Others think that this is one more
example of the increasing medicalisation of pregnancy.
But we need to remember that the test would be optional, not mandatory. The decision must be up to the
pregnant woman, backed up with good support from health professionals.
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